Skip to content

Clinical trials

Phase 3 Hearing Loss trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hearing Loss Phase: Phase 3 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20151
20161
20221
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed2
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sound Pharmaceuticals, Incorporated2
Auris Medical AG1
Auris Medical, Inc.1
Eli Lilly and Company1
House Research Institute1
Johns Hopkins University1
Leiden University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hearing Loss8
Meniere Disease4
Tinnitus4
Deafness3
Dizziness3
Hearing Loss, Sensorineural3
Vertigo3
Ear Diseases2
Hearing Disorders2
Hearing Loss, Unilateral2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.